Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
Nuanpan Tangtavorn, Yosanan Yospaiboon, Tanapat Ratanapakorn, Suthasinee Sinawat, Thuss Sanguansak, Chavakij Bhoomibunchoo, Wipada Laovirojjanakul KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand Objective: To study the incidences of and r...
Guardado en:
Autores principales: | Tangtavorn N, Yospaiboon Y, Ratanapakorn T, Sinawat S, Sanguansak T, Bhoomibunchoo C, Laovirojjanakul W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b2dc6fe31f454fb080074e03705274dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
por: Jarir At Thobari
Publicado: (2021) -
Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
por: Kavous Shahsavarinia, et al.
Publicado: (2021) -
Chloroquine/Hydroxychloroquine Use and Suicide Risk: Hypotheses for Confluent Etiopathogenetic Mechanisms?
por: Alessandra Costanza, et al.
Publicado: (2021) -
Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines
por: Browning DJ, et al.
Publicado: (2018) -
Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions
por: Mayra Souza Botelho, et al.
Publicado: (2021)